Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Edison Investment Research
$10.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

CLINICAL BIOMECHANICS Publishes Study Proving Positive Performance of Vexim SA's SpineJack-DJ


Thursday, 12 Sep 2013 11:45am EDT 

Dow Jones reported that Vexim SA announced that the results of a comparative biomechanical study carried out by Marburg University's Traumatology department (Germany) were published in the August issue of the CLINICAL BIOMECHANICS international journal. The aim of this study was to evaluate the anatomic restoration of 36 fractured vertebral bodies with osteoporosis and the maintaining of the gained height after recompression by comparing the Company's SpineJack and balloon kyphoplasty techniques. The results obtained demonstrate an advantage in favor of the SpineJack regarding the restoration of vertebral height that is carried out to reestablish the spinal column's balance. 

Company Quote

10.81
 --
30 Oct 2014